)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Beijing Tong Ren Tang Chinese Medicine Company
Beijing Tong Ren Tang Chinese Medicine Company (3613) investor relations material
Beijing Tong Ren Tang Chinese Medicine Company H1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H1 2026 earnings summary28 Aug, 2026
Executive summary
Revenue for the six months ended 30 June 2026 was HK$601.9 million, down 21.0% year-over-year, with profit attributable to owners at HK$198.2 million, down 15.6%.
Gross profit margin improved to 63.9% from 60.8% year-over-year, reflecting effective cost control and product mix optimization.
The company maintained a strong capital structure, low debt, and ample liquidity, with a current ratio of 21.0.
Strategic tightening of proprietary product distribution led to a 27.8% drop in wholesale revenue, while Hong Kong retail revenue grew 5% year-over-year.
New product launches and international expansion, including GMP certification in Vietnam and new partnerships in Russia and ASEAN, marked significant progress.
Financial highlights
Revenue: HK$601.9 million (down 21.0% year-over-year).
Gross profit: HK$384.7 million (down 16.9% year-over-year).
Profit before income tax: HK$233.4 million (down 19.4% year-over-year).
Profit attributable to owners: HK$198.2 million (down 15.6% year-over-year).
Earnings per share: HK$0.24 (down from HK$0.28 year-over-year).
Outlook and guidance
Focus on deepening the “2+2+N” product strategy, expanding core and innovative product lines.
Plans to scale up overseas sales, especially in ASEAN, leveraging new GMP certifications and pursuing multi-country product registration.
Store revitalization and global supply chain improvements are key priorities for the second half of 2026.
Emphasis on AI-powered TCM diagnosis and digital transformation to drive future growth.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Beijing Tong Ren Tang Chinese Medicine Company
- Revenue and profit fell, but cash and equity rose; global expansion and innovation prioritized.3613
H2 2025 - Revenue and profit rose, driven by expansion, innovation, and strong cash position.3613H1 2025
- Revenue and profit fell over 17% year-over-year, but liquidity and R&D investment stayed strong.3613H1 2024
- Revenue up 5.7% but net profit down 10.4% as Overseas sales fell and costs rose.3613H2 2024
Next Beijing Tong Ren Tang Chinese Medicine Company earnings date
H2 202619 Mar, 2027
Beijing Tong Ren Tang Chinese Medicine Company
Next Beijing Tong Ren Tang Chinese Medicine Company earnings date
H2 202619 Mar, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Beijing Tong Ren Tang Chinese Medicine Company Limited is a pharmaceutical company specializing in the production, retail, and distribution of traditional Chinese medicine (TCM). The company leverages its heritage and expertise to develop a wide range of herbal products, including proprietary Chinese medicines, granules, and healthcare supplements. With a strong focus on quality and adherence to traditional preparation methods, Beijing Tong Ren Tang serves markets globally, catering to customers seeking alternative and complementary medical products. The company is headquartered in Hong Kong, China, and its shares are listed on the Hong Kong Stock Exchange.